PYC 0.00% 12.0¢ pyc therapeutics limited

Ann: PYC Corporate Presentation - February 2023, page-12

  1. 4,960 Posts.
    lightbulb Created with Sketch. 1036
    Great post! Hope you don’t mind me asking a couple of questions.

    A biology question: on P 18 we see the results that show that diseased cells revert to a more normal phenotype when treated with VP001. Does this mean that patients who have lost their sight to RP11 regain it, or will it stop further loss of vision (but they don’t recover what they lost?)

    Financial question: It’s great to estimate potential incomes (number of patients x $150,000) but PYC won’t attain that as it hasn’t the $$$ to put the treatments through trials. So that means out-licensing. What % of the income could we hope to receive via license fees?

    cheers
    FHC
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
(20min delay)
Last
12.0¢
Change
0.000(0.00%)
Mkt cap ! $559.9M
Open High Low Value Volume
12.5¢ 12.5¢ 12.0¢ $48.86K 395.4K

Buyers (Bids)

No. Vol. Price($)
9 557634 12.0¢
 

Sellers (Offers)

Price($) Vol. No.
12.5¢ 228758 18
View Market Depth
Last trade - 14.24pm 28/06/2024 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.